Risk factors and complications of type 2 diabetes in Asians
|
|
- Mae Wilkinson
- 8 years ago
- Views:
Transcription
1 Risk factors and complications of type 2 diabetes in Asians Rajbharan Yadav, Pramil Tiwari* and Ethiraj Dhanaraj Department of Pharmacy Practice National Institute of Pharmaceutical Education and Research Sector 67, S.A.S. Nagar, Punjab, India * Corresponding author Dr. Pramil Tiwari, ptiwari@niper.ac.in Type 2 diabetes mellitus is the commonest form of diabetes constituting 90% of the diabetes population. The acute and chronic complications of diabetes mellitus are major causes of hospital admissions. Studies identified that the prevalence of microvascular and macro vascular complications were more in Asians when compared to Europeans. Common risk factors like greater duration of diabetes, hypertension, poor metabolic control, smoking, obesity and dyslipidemia were more prone to develop diabetic complications. Microvascular diseases were common amongst patients at diagnosis In India. The morbidity and mortality caused by diabetes mellitus can be reduced by secondary prevention through regular screening, early detection, and appropriate treatment of chronic complications. Introduction Type 2 diabetes mellitus (T2DM) is the commonest form of diabetes constituting 90% of the diabetic population. The global prevalence of diabetes is estimated to increase from 4% in 1995 to 5.4% by the year The World Health Organization has predicted that the major burden will occur in the developing countries and there will be a 42% increase (from 51 to 72 million) in the developed countries and 170% increase (from 84 to 228 million) in the developing countries. The countries with the largest number of diabetes patients are, and will be in the year 2025, India, China and United States 1, 2, 3. The number of diabetes patients in India currently around 40.9 million is expected to rise to 80 million by In developing countries, the majority of diabetes patients are in the age range of years whereas in the developed countries are aged > 65 years 3. The so-called Asian Indian Phenotype refers to certain unique clinical and biochemical abnormalities in Indians which include increased insulin resistance, higher waist circumference despite lower body mass index, lower adiponectin and higher high sensitive C-reactive protein levels. This phenotype makes Asians more prone to diabetes and premature coronary artery disease 4. The acute and chronic complications of diabetes mellitus are major causes of hospital admissions. Asian patients had more evidence of macro and micro vascular disease at diagnosis of diabetes 8. Several studies showed that the prevalence of microvascular and macrovascular complications were more in Asians when compared to Europeans 8. Lifestyle modifications such as weight control, increased physical exercise, and smoking cessation are also potentially beneficial in preventing diabetes mellitus and coronary artery disease 5. In this review the risk factors and complications in type 2 8 diabetes mellitus in Asians are discussed. Microvascular complications Microvascular complications include retinopathy, nephropathy, and neuropathy. Diabetic retinopathy (DR) can be defined as damage to microvascular system in the retina due to prolonged hyperglycaemia. Diabetic retinopathy is primarily classified into non proliferative diabetic retinopathy (NPDR), or background retinopathy, and proliferative diabetic retinopathy (PDR). Progression from mild form characterized by increased vascular permeability, to moderate, and then to severe NPDR characterized by vascular closure and an increased risk for the development of PDR distinguished by the growth of new blood vessels on the retina and posterior surface of the vitreous. Visual impairment in diabetic retinopathy occurs due to diabetic macular edema (DME) and PDR 6, 10. Diabetic nephropathy is the kidney disease that occurs as a result of diabetes. Nephropathy is the leading cause of chronic renal failure worldwide and is responsible for renal failure in about one third of patients who undergo dialysis. One of the initial markers of this condition is microalbuminuria, which indicates an increased risk of progression to nephropathy as well as an elevated risk of cardiovascular events 5. A test for the presence of microalbumin should be performed at diagnosis in patients with T2DM. Screening for microalbuminuria can be performed by three methods: 1) measurement of the albumin-to-creatinine ratio in a random spot collection; 2) 24 h urine collection with creatinine, allowing the simultaneous measurement of creatinine clearance and 3) timed (e.g., 4 h or overnight) collection 7. The diagnostic criteria for the albuminuria are summarized in Table 1.
2 Table 1 Definitions of abnormalities in albumin excretion Category Spot collection 24h collection Timed collection (μg/mg creatinine) (mg/24 h) (μg/min) Normal <30 <30 <20 Microalbuminuria Clinical albuminuria >300 >300 >200 Ref; (7) Diabetic neuropathies are a family of nerve disorders caused by diabetes. It can be classified as peripheral, autonomic, proximal, and focal. Each affects different parts of the body in different ways. Diabetic foot ulcers may develop, mainly because of the abnormal distribution of pressure. The early detection of diabetic neuropathy results in less hospitalization of patients with foot ulcers and fewer lower-extremity amputations 5. Screening for neuropathy can be done reliably by using the 10-g Semmes-Weinstein monofilament over 10 areas of the feet, ankle reflexes and vibration perception over the great toe and ankle. A standard neuropathy disability score (NDS) will be measured and a score of over 6 shows the presence of significant neuropathy is present. One of the most common complications of diabetes in the lower extremity is the diabetic foot ulcer which is often ignored. Diabetes patients are victims of a number of problems specific to their disease that results in increased amputation rates because of the complications of neuropathy and infection. The risks of these all microvascular conditions can be significantly reduced by optimizing glycemic control and if they are detected and treated early through patient education and regular screening 8,13. Macrovascular complications Macrovascular complications include coronary artery disease (CAD), Peripheral vascular disease (PVD), and cerebrovascular events (CVA). Diabetes mellitus is an independent risk factor for the development of atherosclerosis. On the other hand, atherosclerotic or macrovascular disease is responsible for more than 50% of all deaths in patients with T2DM. Cardiovascular disease accounts for most cases of diabetic macrovascular complications and the remaining are caused by cerebrovascular events and peripheral vascular disease 5. In India, escalating population levels of major coronary risk factors have contributed to the coronary heart disease epidemic. Several studies shows that parallel to the increase in Chronic Heart Disease (CHD) in Indian urban populations there has been an increase in prevalence of hypertension, diabetes, high LDL cholesterol, low HDL cholesterol and the metabolic syndrome 11. Mortality among diabetic patients with CAD is higher than non-diabetic subjects. Studies have also shown that myocardial infraction in diabetics was more common than non-diabetics 12. Indian seems to be more predisposed to both diabetes and CAD. PVD is defined as disease of any blood vessel that is not part of heart or brain. The more common form of PVD is observed in lower extremity which is termed as the Lower extremity arterial disease (LEAD). The simplest screening test for PVD is palpitation of peripheral pulses and this is the usual clinical tool to assess the occlusive arteries in peripheries. Absence of peripheral, tibial, popliteal or femoral pulses on peripheral examination are clinically significant. Several techniques used for diagnosis of PVD are angiography, colour duplex ultrasound, and continuous waveform doppler 13. Hypertension is the primary preventable cause of the two major causes of mortality: coronary artery disease (CAD), and cerebrovascular disease (CVD). It increases the risk for CAD by two fold, CVD by seven folds and congestive heart failure by four fold. There is ample evidence for a consistent gradient relationship of blood pressure with CVD and CAD. Studies have also shown that an increase of blood pressure of 5 mm Hg is associated with a 34% increase in risk for CVD and a 21% excess risk for CAD 14,15. Other complications Depression is twice as much common in people with diabetes as in the general population and major depression is present in at least 15% of patients with diabetes. Depression is associated with poorer glycemic control, health complications, decreased quality of life and increased healthcare costs. People with diabetes should be screened for depression regularly, either with direct questioning (e.g. during the past month, have you often been bothered by feeling down, depressed, or hopeless? and during the past month, have you often been bothered by little interest or pleasure in doing things? ) or with a standardized questionnaire 16. The other complication in diabetic men is erectile dysfunction (ED) and the prevalence was 34 to 45%. Risk factors include increasing age, duration of diabetes, poor glycemic control, cigarette smoking, hypertension, dyslipidemia and cardiovascular disease. Microvascular, macrovascular complications, psychological and situational factors may also cause or contribute to ED. In addition to this ED is a side effect of many drugs commonly prescribed to men with diabetes, such as antihypertensive (beta-blockers and thiazide diuretics) and antidepressants. All adult men with diabetes 9
3 should be periodically screened for ED with a sexual function history and screening for ED in men with T2DM should begin at diagnosis of diabetes 17. Prevalence of microvascular and macrovascular complications Long-standing diabetes mellitus is associated with an increased prevalence of microvascular and macrovascular diseases. With the rising prevalence of diabetes, the numbers suffering from the vascular complications of diabetes will also increase 2. A study was conducted in India on prevalence of microvascular and macrovascular complications in T2DM patients. It was found that prevalence of retinopathy (23.7%), among which background retinopathy was 20% and proliferative was 3.7% 2,3. In Hong Kong, a cross-sectional study was conducted, which revealed the 19% nonproliferative and 3% proliferative retinopathy 4. The prevalence of retinopathy between 1990 and 1996 for patients with newly diagnosed T2DM was 22% in Hong Kong 5. The prevalence of nephropathy in India was less (8.9% in Vellore, 5.5% in Chennai) when compared with the prevalence of 22.3% in Asian Indians in the UK 2. The prevalence of diabetic nephropathy was 30.3% followed by chronic interstitial nephritis (23%) and chronic glomerulonephritis (17.7%) in chronic renal failure patients 1. The prevalence of neuropathy in Indians was 27.5%, which was more when compared to that in Hong Kong (13%) 4. A study had indicated that the risk of CVD was 3-fold higher in nephropathy group than in the nonproteinuric subjects (39 vs. 13.2%). The prevalence of CVD in India was found to be 11.4%, which was higher than other Asian countries 2. Another study showed that the prevalence of CVD indicated by major Q wave changes was found to be 3.9%, which was similar to the prevalence in the Asian Indians in UK (4.0%) 2. Prevalence of PVD in Asian Indians is comparatively low compared with the white population (9.3%). Low prevalence of PVD was demonstrated in Indian patients (4.0%). Although the prevalence of PVD is low, but the neuropathy is very common and is an associated risk factor for diabetic foot infections. Hypertension develops in people with T2DM at the rate twice than those who are non-diabetic. Hypertension is a major contributor to atherosclerotic diseases and can lead to a more rapid progression of nephropathy and renal failure. The prevalence of hypertension was 38 % in Indians while CVA was only noted in 0.9% type 2 diabetes patients 12. Diabetes and its complication in young subjects between different parts of Asian countries shows the prevalence of diabetic retinopathy was significantly lower in younger Indians (5.3%) compare to other ethnic groups like Malaysia (10.8%) and China (15.1%) 6. It was estimated that diabetic foot ulcer was the most expensive complication and approximately 40 to 72 % of all lower extremity amputations were related to diabetes. Recurrence rates for foot ulcer in neuropathic subjects were estimated at 52 % in a study carried out in 374 patients in southern India 4. A comparative study of Asians vs Europeans and Americans was conducted which concludes that the prevalence of macrovascular disease was higher in Asians compared to Europeans (Table 2). Asian patients had more evidence of macro and micro vascular disease at diagnosis of diabetes, compared to European patients. History of ischemic disease was significantly more common in Asians and Americans 8,20. Microvascular diseases were more common amongst Asian patients at diagnosis. Asians had significantly more background retinopathy at diagnosis, including proliferative retinopathy (3.6% vs. 1.6%) 8. Asians and Americans also had a significantly higher prevalence of microalbuminuria and macroalbuminuria, although serum creatinine was similar between two groups. Neuropathy was more in the American patients, although this was not significant 19. Table 2: Prevalence of Micro/Macrovascular complications in Asian and European Complications European Americans Asian Microvascular Neuropathy (%) Microalbuminuria (%) Macroalbuminuria (%) Background Retinopathy (%) Proliferative retinopathy (%) Macrovascular H/O Ischaemic disease (%) Evidence of Macrovascular disease (%) Ref; (8,19) 10
4 Risk factors The important risk factors for the high prevalence of diabetes include: (1) High familial aggregation, (2) Obesity especially central obesity, (3) Insulin resistance and metabolic syndrome, (4) Life style changes due to urbanization 2, (5) Gestational diabetes. Several studies in India and abroad have shown that nearly 75% of the T2DM patients have first degree family history of diabetes, this indicates a strong familial aggregation in the Indian diabetic patient. Insulin resistance has been demonstrated to be a characteristic feature of Asian Indians 3. A comparative study of Asian Indians, Europeans and other ethnic groups have shown that the Asian Indians have higher insulin response than others, at fasting and in response to glucose. Insulin resistance and the compensatory increase in insulin secretion bring about a state of chronically increased insulin and glucose levels in the blood (hyperinsulinemia and hyperglycemia) and thus is a predecessor for diabetes 8. Central adiposity indicates deposition of large quantities of abdominal fat, which consists of visceral fat and subcutaneous fat. Visceral fat increases the risk of diabetes and hyperlipidaemia by favouring insulin resistance. In several ethnic populations including the relatively non-obese Asians population, the android pattern of body fat, typified by more upper body adiposity measured as waist:hip ratio was found to be a greater risk factor for T2DM than general obesity 2, 11. Another study concluded that a continuous positive relationship of all markers of obesity (body-mass index, waist size and waist:hip ratio) with major coronary risk factorshypertension, diabetes and metabolic syndrome while waist hip ratio also correlates with lipid abnormalities 11. Urbanization has brought several changes in the life style in most urban areas in India and it is associated with greater prevalence Table 3: Cardiovascular risk factors in European, Americans and Asian Review Article of diabetes and coronary risk factors in populations of developing countries and is considered a proximate coronary risk factor 8,11. Gestational diabetes is a strong risk factor for diabetes 11. Risk factors for development of complications One study by Harney F et al suggested that some common risk factors like greater duration of diabetes, hypertension, poor metabolic control, smoking, obesity and hyperlipidemia were more prone to develop diabetic complications 10. T2DM increases the risk of coronary events two fold in men and four fold in women. Part of this increase is due to the frequency of associated cardiovascular risk factors such as hypertension, dyslipidemia, and clotting abnormalities. In observational studies, people with both diabetes and hypertension have approximately twice the risk of cardiovascular disease as nondiabetic people with hypertension 20. In a retrospective study done by Klag et al it has been found that elevations of blood pressure are a strong independent risk factor for end-stage renal disease and interventions to prevent the disease need to emphasize the prevention and control of both high-normal and high blood pressure. 21 A comparative study was conducted for assessment of cardiovascular risk factors (Table 3) has shown that Asians had a slightly lower BMI, but significantly greater waist: hip ratio. Asians showed a trend towards higher systolic and diastolic blood pressures, possibly due to more patients with nephropathy, but this was not significantly different 8. Total cholesterol and LDL cholesterol levels were very similar between all three groups, but HDL cholesterol was significantly lower and triglycerides significantly higher in Asian patients 8. Current smokers were more common in Americans (15.4%) whereas Asians were more at risk of Risk factors Europeans Americans Asians Current smokers (%) Body mass index kg/m ± ±5.3 26±5.4 Waist : hip ratio 0.90 ± ± ±0.2 Systolic BP (mmhg) 123 ± ±10 Diastolic BP mean (mmhg) 76±7-80±5 LVH on ECG (%) Total cholesterol (mg/dl) 209±46 212± ±50 LDL cholesterol (mg/dl) 135±27 138± ±31 HDL cholesterol (mg/dl) 50±7.8 50± ±11.6 Triglycerides (mg/dl) 133±35 151±35 168±44 CHD risk (%) Ref; (8,19) 11
5 Table 4: Cardiovascular risk factors in Type 2 diabetes Non-modifiable risk factors Age Male sex Family history Newer risk factors Lipoprotein Homocysteine Plasma fibrinogen Tissue plasminogen activator Plasminogen activator inhibitor-1 C-Reactive protein Ref; (2) CHD among all three groups 19. Another study was conducted in Asians has shown that prevalence of cardiovascular risk factors were in the order of central adiposity, dyslipidemia, hyperinsulinemia, glucose intolerance, obesity and hypertension 9. Cardiovascular risk factors in diabetes patients are summarized in table 4: Preventive Measures Lifestyle modification such as weight control, increased physical exercise, and smoking cessation which are potentially beneficial in preventing diabetes mellitus and its complication 5. People should be encouraged to adopt the preventive interventions of diabetes like maintaining normal body weight (BMI kg/m2), engage in regular aerobic physical activity such as brisk walking (at least 30 min per day, most days of the week), limit consumption of alcohol and consume a diet rich in fruits, vegetables, low fat dairy products. Several studies of community-based non communicable disease prevention projects attempted to prevent the onset of diabetes through life style modification, reduction in obesity or through pharmacological mean and clearly demonstrated risk factors reduction by healthy life style bring a huge benefit to the public 22. Community-based strategies for prevention of diabetes are following: 1) primary prevention, 2) secondary prevention, 3) tertiary prevention. Among three former one related with lifestyle modifications. The primary prevention includes two approaches, high risk approach and population approach. The high risk strategy primarily aim to bring preventive care to individuals with a family history of diabetes who carry a genetic susceptibility, individuals with impaired glucose tolerance, aging individuals, sedentary individuals and obese proportion of population. Population strategy aims to lower the mean level of risk for the entire population by increasing 12 Modifiable risk factors Cigarette smoking Obesity Diabetes Elevated cholesterol Hypertension Behavioural risk factors Protective factors Exercise HDL cholesterol Stress reduction physical activity, improving diet and reducing obesity 23. Conclusions Type 2 diabetes mellitus has rapidly become a global health problem with rapid worldwide increasing population growth, aging, urbanization and increasing prevalence of obesity and physical inactivity indicating the urgent need to prevent diabetes and its complications rather than simply treat it, once established. Patients should be educated for lifestyle changes such as weight control, increased physical exercise, and smoking cessation, which are potentially beneficial in preventing diabetes mellitus and coronary artery disease. Furthermore, the morbidity and mortality caused by diabetes mellitus can be reduced by secondary prevention through regular screening, early detection, and appropriate treatment of chronic complications. In many developing countries in Asia, the limited health care resources must be rationally allocated to programmes of proven efficacy. This is a tough challenge indeed, and the decisions made will influence the quality of diabetes care in Asia. References 1. King H, Auburt RE, Herman WH. Diabetes Care. 1998; 21: Ramachandran A, Snehalatha C, Viswanathan V. Current Science 2002; 83:12: Ramachandran A. Socioeconomic burden of diabetes in India. Suppl. JAPI 2007; 55:9 4. Mohan V, Sandeep S, Deepa R. Indian scenario. Indian J Med Res 2007; 125: Leung GM, Lam K. HKMJ 2000; 6: Rema M, Pradeepa R. Indian Med J Res 2007; 125: American diabetic association. Nephropathy in diabetes: Diabetes Care. 2004; 27:S Chowdhary TA, Lasker SS. Q J Med 2002; 95: Deepa R, Mohan V. Current Science 2002; 83:12: Harney F. Medicine 2006; 34:3: Gupta R, Rastogi P, Sarna M, Sharma SK. JAPI 2007; 55: Haffner SM, Lehto S, Laakso M. N Engl J Med 1998; 330: Beach KW, Bedford GR. Diabetes Care. 1998; 11: Kannel WB. Drugs Ageing. 2003; 20: Stamler J. 1991; 18:I95-I Groot M, Anderson R, Kenneth E. Psychosomatic Medicine 2001; 63: Ofra KL, Murad H, Raz I. Diabetes Care. 2005; 28: Ruwaared D, Annemieke MW, Coen DA. Diabetes Care 2003; 26: Selvin E, Coresh J, Frederick LB. Diabetes Care 2006; 29: Arauz-Pacheco C, Parrott MA, Raskin P. Diabetes Care. 2004; 27:S65-S Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, et al. N Engl J Med. 1996; 334: Integrated community-based prevention of major noncommunicable disease in SEAR-Report of an informal consultation, WHO SEARO, New Delhi, India 2003; King H, Kriska AM. Diabetes Care 1992; 15:4:1794.
TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION. Robert Dobbins, M.D. Ph.D.
TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION Robert Dobbins, M.D. Ph.D. Learning Objectives Recognize current trends in the prevalence of type 2 diabetes. Learn differences between type 1 and type
More informationGuidelines for the management of hypertension in patients with diabetes mellitus
Guidelines for the management of hypertension in patients with diabetes mellitus Quick reference guide In the Eastern Mediterranean Region, there has been a rapid increase in the incidence of diabetes
More informationUnderstanding diabetes Do the recent trials help?
Understanding diabetes Do the recent trials help? Dr Geoffrey Robb Consultant Physician and Diabetologist CMO RGA UK Services and Partnership Assurance AMUS 25 th March 2010 The security of experience.
More informationDISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD
STROKE AND HEART DISEASE IS THERE A LINK BEYOND RISK FACTORS? D AN IE L T. L AC K L AN D DISCLOSURES Member of NHLBI Risk Assessment Workgroup RISK ASSESSMENT Count major risk factors For patients with
More informationMetabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007
Metabolic Syndrome Overview: Easy Living, Bitter Harvest Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007 Evolution of Metabolic Syndrome 1923: Kylin describes clustering
More informationRole of Body Weight Reduction in Obesity-Associated Co-Morbidities
Obesity Role of Body Weight Reduction in JMAJ 48(1): 47 1, 2 Hideaki BUJO Professor, Department of Genome Research and Clinical Application (M6) Graduate School of Medicine, Chiba University Abstract:
More informationDiabetes mellitus is a chronic condition that occurs as a result of problems with the production and/or action of insulin in the body.
International Diabetes Federation Diabetes Background Information Diabetes mellitus is a chronic condition that occurs as a result of problems with the production and/or action of insulin in the body.
More informationMortality Associated with Diabetes
Mortality Associated with Diabetes A review paper prepared for the 7th Global Conference of Actuaries, New Delhi, 15-16 February, 2005 Dr. David Muiry, MB;BS, FIA, FASI David_Muiry@swissre.com Introduction
More informationDiabetes mellitus. Lecture Outline
Diabetes mellitus Lecture Outline I. Diagnosis II. Epidemiology III. Causes of diabetes IV. Health Problems and Diabetes V. Treating Diabetes VI. Physical activity and diabetes 1 Diabetes Disorder characterized
More informationDiabetic Nephropathy
Diabetic Nephropathy Kidney disease is common in people affected by diabetes mellitus Definition Urinary albumin excretion of more than 300mg in a 24 hour collection or macroalbuminuria Abnormal renal
More information1. PATHOPHYSIOLOGY OF METABOLIC SYNDROME
1. PATHOPHYSIOLOGY OF METABOLIC SYNDROME Izet Aganović, Tina Dušek Department of Internal Medicine, Division of Endocrinology, University Hospital Center Zagreb, Croatia 1 Introduction The metabolic syndrome
More informationCardiovascular Disease Risk Factors Part XII Insulin Resistance By James L. Holly, MD Your Life Your Health The Examiner September 15, 2005
Cardiovascular Disease Risk Factors Part XII By James L. Holly, MD Your Life Your Health The Examiner September 15, 2005 As we approach the end of our extended series on cardiovascular disease risk factors,
More informationDIABETES A chronic, debilitating and often deadly disease A global epidemic Diabetes in Africa
DIABETES A chronic, debilitating and often deadly disease Diabetes is a chronic condition that arises when the pancreas does not produce enough insulin, or when the body cannot effectively use the insulin
More informationHigh Blood Cholesterol
National Cholesterol Education Program ATP III Guidelines At-A-Glance Quick Desk Reference 1 Step 1 2 Step 2 3 Step 3 Determine lipoprotein levels obtain complete lipoprotein profile after 9- to 12-hour
More informationHow To Determine The Prevalence Of Microalbuminuria
Research Journal of Pharmaceutical, Biological and Chemical Sciences Prevalence of Microalbuminuria in relation to HbA1c among known Type2 Diabetic Patients in Puducherry population Muraliswaran P 1 *,
More informationDIABETES YOUR GUIDE TO
YOUR GUIDE TO DIABETES b What is diabetes? b Type 2 diabetes prevention b Prevention checklist b Living with diabetes b Complications b Terms to know b Resources To promote and protect the health of Canadians
More informationCardiovascular disease physiology. Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011
Cardiovascular disease physiology Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011 Content Introduction The number 1 killer in America Some statistics Recommendations The disease process
More informationTreatment of diabetes In order to survive, people with type 1 diabetes must have insulin delivered by a pump or injections.
National Diabetes Statistics What is diabetes? Diabetes mellitus is a group of diseases characterized by high levels of blood glucose resulting from defects in insulin production, insulin action, or both.
More informationDiabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria.
Kidney Complications Diabetic Nephropathy Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria. The peak incidence of nephropathy is usually 15-25 years
More informationUse of Glycated Hemoglobin and Microalbuminuria in the Monitoring of Diabetes Mellitus
Agency for Healthcare Research and Quality Evidence Report/Technology Assessment Number 84 Use of Glycated Hemoglobin and Microalbuminuria in the Monitoring of Diabetes Mellitus Summary Overview Clinical
More informationCHAPTER V DISCUSSION. normal life provided they keep their diabetes under control. Life style modifications
CHAPTER V DISCUSSION Background Diabetes mellitus is a chronic condition but people with diabetes can lead a normal life provided they keep their diabetes under control. Life style modifications (LSM)
More informationPrevalence of Micro and Macrovascular Complications and their Risk Factors in Type-2 Diabetes Mellitus
44 Journal of the association of physicians of india vol 62 published on 1st of every month 1st june, 2014 review article Prevalence of Micro and Macrovascular Complications and their Risk Factors in Type-2
More informationStroke: Major Public Health Burden. Stroke: Major Public Health Burden. Stroke: Major Public Health Burden 5/21/2012
Faculty Prevention Sharon Ewer, RN, BSN, CNRN Stroke Program Coordinator Baptist Health Montgomery, Alabama Satellite Conference and Live Webcast Monday, May 21, 2012 2:00 4:00 p.m. Central Time Produced
More informationHow To Know If You Have Microalbuminuria
3 PREVALENCE AND PREDICTORS OF MICROALBUMINURIA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A CROSS-SECTIONAL OBSERVATIONAL STUDY Dr Ashok S Goswami *, Dr Janardan V Bhatt**; Dr Hitesh Patel *** *Associate
More informationInsulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both.
Diabetes Definition Diabetes is a chronic (lifelong) disease marked by high levels of sugar in the blood. Causes Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused
More informationCardiovascular Risk in Diabetes
Cardiovascular Risk in Diabetes Lipids Hypercholesterolaemia is an important reversible risk factor for cardiovascular disease and should be tackled aggressively in all diabetic patients. In Type 1 patients,
More informationType 1 Diabetes ( Juvenile Diabetes)
Type 1 Diabetes W ( Juvenile Diabetes) hat is Type 1 Diabetes? Type 1 diabetes, also known as juvenile-onset diabetes, is one of the three main forms of diabetes affecting millions of people worldwide.
More informationHow To Treat Dyslipidemia
An International Atherosclerosis Society Position Paper: Global Recommendations for the Management of Dyslipidemia Introduction Executive Summary The International Atherosclerosis Society (IAS) here updates
More informationGUIDELINES FOR THE TREATMENT OF DIABETIC NEPHROPATHY*
71 GUIDELINES FOR THE TREATMENT OF DIABETIC NEPHROPATHY* Ryuichi KIKKAWA** Asian Med. J. 44(2): 71 75, 2001 Abstract: Diabetic nephropathy is the most devastating complication of diabetes and is now the
More informationNutrition. Type 2 Diabetes: A Growing Challenge in the Healthcare Setting NAME OF STUDENT
1 Nutrition Type 2 Diabetes: A Growing Challenge in the Healthcare Setting NAME OF STUDENT 2 Type 2 Diabetes: A Growing Challenge in the Healthcare Setting Introduction and background of type 2 diabetes:
More informationWHAT DOES DYSMETABOLIC SYNDROME MEAN?
! WHAT DOES DYSMETABOLIC SYNDROME MEAN? Dysmetabolic syndrome (also referred to as syndrome X, insulin resistance syndrome, and metabolic syndrome ) is a condition in which a group of risk factors for
More informationDIABETES CARE. Advice. Blood Pressure. Cholesterol. Diabetes control. Eyes. Feet. Guardian Drugs
DIABETES CARE What happens if you follow the Alphabet Strategy? As patients reach their targets, the chances of developing serious complications of diabetes will be reduced! 1 Stroke Eye disease Heart
More informationDiabetes Brief. Pre diabetes occurs when glucose levels are elevated in the blood, but are not as high as someone who has diabetes.
Diabetes Brief What is Diabetes? Diabetes mellitus is a disease of abnormal carbohydrate metabolism in which the level of blood glucose, or blood sugar, is above normal. The disease occurs when the body
More informationDiabetes and Hypertension Care For Adults in Primary Care Settings
and Hypertension Care For Adults in Primary Care Settings What is Type 2? The carbohydrates including sugar and starch which we take become glucose after digestion. It will then be absorbed by the small
More informationDiabetes and Heart Disease
Diabetes and Heart Disease Diabetes and Heart Disease According to the American Heart Association, diabetes is one of the six major risk factors of cardiovascular disease. Affecting more than 7% of the
More informationType 2 Diabetes Mellitus and Insulin resistance syndrome in Children
Type 2 Diabetes Mellitus and Insulin resistance syndrome in Children Anil R Kumar MD Pediatric Endocrinology MCV/VCU, Richmond VA Introduction Type 2 diabetes mellitus (T2 DM) has increased in children
More informationDeakin Research Online
Deakin Research Online This is the published version: Cameron, Adrian J., Shaw, J.E. and Zimmet, P.Z. 2003, Diabetes, in Diabetes and kidney disease : time to act, nternational Diabetes Federation, Brussels,
More informationADULT HYPERTENSION PROTOCOL STANFORD COORDINATED CARE
I. PURPOSE To establish guidelines for the monitoring of antihypertensive therapy in adult patients and to define the roles and responsibilities of the collaborating clinical pharmacist and pharmacy resident.
More informationOverview and update of modern type 2 Diabetes philosophy and management. Dr Steve Stanaway Consultant Endocrinologist BCU
Overview and update of modern type 2 Diabetes philosophy and management Dr Steve Stanaway Consultant Endocrinologist BCU Diabetes economics 2009: 2.6M adults with DM in UK (90% type 2) 2025: est. > 4M
More informationADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes
ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes Effects of a fixed combination of the ACE inhibitor, perindopril,
More informationGuidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes
Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes U.S. Department of Health and Human Services Food and Drug Administration Center
More informationDiabetes, hypertension and a lot more `in the elderly` JORIS SCHAKEL INTERNIST- CLINICAL GERIATRICIAN JGSCHAKEL@SEHOS.CW
Diabetes, hypertension and a lot more `in the elderly` JORIS SCHAKEL INTERNIST- CLINICAL GERIATRICIAN JGSCHAKEL@SEHOS.CW IT`S HARD TO GIVE GENERAL ADVICE! ``The Elderly`` Heterogeneous group ;widely varying
More informationAbsolute cardiovascular disease risk assessment
Quick reference guide for health professionals Absolute cardiovascular disease risk assessment This quick reference guide is a summary of the key steps involved in assessing absolute cardiovascular risk
More informationDCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study
DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study National Diabetes Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH What
More informationTreating Patients with PRE-DIABETES David Doriguzzi, PA-C First Valley Medical Group. Learning Objectives. Background. CAPA 2015 Annual Conference
Treating Patients with PRE-DIABETES David Doriguzzi, PA-C First Valley Medical Group Learning Objectives To accurately make the diagnosis of pre-diabetes/metabolic syndrome To understand the prevalence
More informationBaskets of Care Diabetes Subcommittee
Baskets of Care Diabetes Subcommittee Disclaimer: This background information is not intended to be a comprehensive scientific discussion of the topic, but rather an attempt to provide a baseline level
More informationPractice Guidelines for the
1 Treatment goals: Practice Guidelines for the The goal of treatment is to keep blood sugar at normal or near-normal levels. This reduces the risk of complications associated with diabetes. A normal fasting
More informationAn Interview with Gerald Reaven: Syndrome X : The Risks of Insulin Resistance
An Interview with Gerald Reaven: Syndrome X : The Risks of Insulin Resistance Gerald Reaven, M.D., is Professor Emeritus (Active) of Medicine at Stanford University. He has served as director of the Division
More informationCME Test for AMDA Clinical Practice Guideline. Diabetes Mellitus
CME Test for AMDA Clinical Practice Guideline Diabetes Mellitus Part I: 1. Which one of the following statements about type 2 diabetes is not accurate? a. Diabetics are at increased risk of experiencing
More informationPrescription Pattern of Anti Hypertensive Drugs used in Hypertensive Patients with Associated Type2 Diabetes Mellitus in A Tertiary Care Hospital
Research Article Prescription Pattern of Anti Hypertensive Drugs used in Hypertensive Patients with Associated Type2 Diabetes Mellitus in A Tertiary Care Hospital *T. JANAGAN 1, R. KAVITHA 1, S. A. SRIDEVI
More informationCardiovascular Disease Risk Factors
Cardiovascular Disease Risk Factors Risk factors are traits and life-style habits that increase a person's chances of having coronary artery and vascular disease. Some risk factors cannot be changed or
More informationDiabetes Mellitus. Melissa Meredith M.D. Diabetes Mellitus
Melissa Meredith M.D. Diabetes mellitus is a group of metabolic diseases characterized by high blood glucose resulting from defects in insulin secretion, insulin action, or both Diabetes is a chronic,
More informationDiabetes and the Kidneys
Diabetes and the Kidneys Aim(s) and objective(s) This guideline focuses on the detection, prevention, and management of kidney disease in people with diabetes. The management of end-stage renal disease
More informationDiabetes Complications
Managing Diabetes: It s s Not Easy But It s s Worth It Presenter Disclosures W. Lee Ball, Jr., OD, FAAO (1) The following personal financial relationships with commercial interests relevant to this presentation
More informationConnecticut Diabetes Statistics
Connecticut Diabetes Statistics What is Diabetes? State Public Health Actions (1305, SHAPE) Grant March 2015 Page 1 of 16 Diabetes is a disease in which blood glucose levels are above normal. Blood glucose
More informationTYPE 2 DIABETES IN THE AFRICAN AMERICAN COMMUNITY. Understanding the Complications That May Happen Without Proper Care
TYPE 2 DIABETES IN THE AFRICAN AMERICAN COMMUNITY Understanding the Complications That May Happen Without Proper Care STAYING HEALTHY THE IMPORTANCE OF PROPER MANAGEMENT OF TYPE 2 DIABETES Diabetes is
More informationCoronary Heart Disease (CHD) Brief
Coronary Heart Disease (CHD) Brief What is Coronary Heart Disease? Coronary Heart Disease (CHD), also called coronary artery disease 1, is the most common heart condition in the United States. It occurs
More informationRenal Disease in Type 2 Diabetes Mellitus
Renal Disease in Type 2 Diabetes Mellitus 6th Collaborative DiGP/HSE/UCC Conference 25 th September 2013 Dr. Eoin O Sullivan Consultant Endocrinologist Bon Secours Hospital Cork Case 69 year old woman
More informationPRESCRIBING GUIDELINES FOR LIPID LOWERING TREATMENTS for SECONDARY PREVENTION
Hull & East Riding Prescribing Committee PRESCRIBING GUIDELINES FOR LIPID LOWERING TREATMENTS for SECONDARY PREVENTION For guidance on Primary Prevention please see NICE guidance http://www.nice.org.uk/guidance/cg181
More informationListen to your heart: Good Cardiovascular Health for Life
Listen to your heart: Good Cardiovascular Health for Life Luis R. Castellanos MD, MPH Assistant Clinical Professor of Medicine University of California San Diego School of Medicine Sulpizio Family Cardiovascular
More informationManaging diabetes in the post-guideline world. Dr Helen Snell Nurse Practitioner PhD, FCNA(NZ)
Managing diabetes in the post-guideline world Dr Helen Snell Nurse Practitioner PhD, FCNA(NZ) Overview Pathogenesis of T2DM Aims of treatment The place of glycaemic control Strategies to improve glycaemic
More informationDIABETES MELLITUS GUIDELINES
DIABETES MELLITUS GUIDELINES Virginia Premier Health Plan Virginia Premier Health Plan, Clinical Practice Guideline-Diabetes 1. Population screening a. Indications i. Adults of any age with body mass index
More informationAn Overview and Guide to Healthy Living with Type 2 Diabetes
MEETING YOUR GOALS An Overview and Guide to Healthy Living with Type 2 Diabetes MEETING YOUR GOALS This brochure was designed to help you understand the health goals to live a healthy lifestyle with type
More informationMY TYPE 2 DIABETES NUMBERS
BLOOD SUGAR MANAGEMENT GUIDE MY TYPE 2 DIABETES NUMBERS Understanding and Tracking the ABCs of Type 2 Diabetes 1 BLOOD MY TYPE SUGAR 2 DIABETES MANAGEMENT ABC NUMBERS GUIDE When you have type 2 diabetes,
More informationDo You Know the Health Risks of Being Overweight?
Do You Know the Health Risks of Being Overweight? U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH WIN Weight-control Information Network What are the risks to my health from
More informationSecondary Stroke Prevention Luke Bradbury, MD 10/4/14 Fall WAPA Conferfence
Guidelines Secondary Stroke Prevention Luke Bradbury, MD 10/4/14 Fall WAPA Conferfence Stroke/TIA Nearly 700,000 ischemic strokes and 240,000 TIAs every year in the United States Currently, the risk for
More informationPowerPoint Lecture Outlines prepared by Dr. Lana Zinger, QCC CUNY. 12a. FOCUS ON Your Risk for Diabetes. Copyright 2011 Pearson Education, Inc.
PowerPoint Lecture Outlines prepared by Dr. Lana Zinger, QCC CUNY 12a FOCUS ON Your Risk for Diabetes Your Risk for Diabetes! Since 1980,Diabetes has increased by 50 %. Diabetes has increased by 70 percent
More informationBlood Pressure Assessment Program Screening Guidelines
Blood Pressure Assessment Program Screening Guidelines Assessment Pre-Assessment Prior to/during assessment, explain to client the following: What is meant by high blood pressure; What are the effects
More informationVascular Risk Reduction: Addressing Vascular Risk
Vascular Risk Reduction: Addressing Vascular Risk Vascular Risk Reduction (VRR) Welcome! Presentation & Activities Focus: Managing known risk factors for vascular disease. Engage, collaborate and have
More informationDiabetes. Patient Education. What you need to know. Diabetes Facts. Improving Health Through Education. What is Diabetes?
Diabetes What you need to know Diabetes Facts More than 3 million Canadians have diabetes (Canadian Diabetes Association, 2009). It is the 4th leading cause of death in the world (CDA, 2009). Patient Education
More informationTHE STUDY OF NEWLY DISCOVERED CASES OF DIABETES MELLITUS IN BIHOR COUNTY
Analele UniversităŃii din Oradea Fascicula:Ecotoxicologie, Zootehnie şi Tehnologii de Industrie Alimentară, 2012 THE STUDY OF NEWLY DISCOVERED CASES OF DIABETES MELLITUS IN BIHOR COUNTY *University of
More informationTERMS FOR UNDERSTANDING YOUR TYPE 2 DIABETES. Definitions for Common Terms Related to Type 2 Diabetes
TERMS FOR UNDERSTANDING YOUR TYPE 2 DIABETES Definitions for Common Terms Related to Type 2 Diabetes TYPE 2 DIABETES AND BLOOD SUGAR 1-3 This list of terms may help you beter understand type 2 diabetes,
More informationDiabetes Mellitus Type 2
Diabetes Mellitus Type 2 What is it? Diabetes is a common health problem in the U.S. and the world. In diabetes, the body does not use the food it digests well. It is hard for the body to use carbohydrates
More informationFamily History and Diabetes. Practical Genomics for the Public Health Professional
Family History and Diabetes Practical Genomics for the Public Health Professional Outline Overview of Type 2 Diabetes/Gestational Diabetes Familial/Genetic Nature of Diabetes Interaction of Genes and Environment
More informationAggressive Lowering of Blood Pressure in type 2 Diabetes Mellitus: The Diastolic Cost
Aggressive Lowering of Blood Pressure in type 2 Diabetes Mellitus: The Diastolic Cost Naftali Stern Institute of Endocrinology, Metabolism and Hypertension Tel Aviv -Sourasky Medical Center and Sackler
More informationProtein Intake in Potentially Insulin Resistant Adults: Impact on Glycemic and Lipoprotein Profiles - NPB #01-075
Title: Protein Intake in Potentially Insulin Resistant Adults: Impact on Glycemic and Lipoprotein Profiles - NPB #01-075 Investigator: Institution: Gail Gates, PhD, RD/LD Oklahoma State University Date
More informationTYPE 2 DIABETES IN CHILDREN DIAGNOSIS AND THERAPY. Ines Guttmann- Bauman MD Clinical Associate Professor, Division of Pediatric Endocrinology, OHSU
TYPE 2 DIABETES IN CHILDREN DIAGNOSIS AND THERAPY Ines Guttmann- Bauman MD Clinical Associate Professor, Division of Pediatric Endocrinology, OHSU Objectives: 1. To discuss epidemiology and presentation
More informationIntroduction. Pathogenesis of type 2 diabetes
Introduction Type 2 diabetes mellitus (t2dm) is the most prevalent form of diabetes worldwide. It is characterised by high fasting and high postprandial blood glucose concentrations (hyperglycemia). Chronic
More informationObesity in the United States Workforce. Findings from the National Health and Nutrition Examination Surveys (NHANES) III and 1999-2000
P F I Z E R F A C T S Obesity in the United States Workforce Findings from the National Health and Nutrition Examination Surveys (NHANES) III and 1999-2000 p p Obesity in The United States Workforce One
More informationGetting Off the Chronic Disease Merry-Go-Round: What s the Weight of the Research?
Getting Off the Chronic Disease Merry-Go-Round: What s the Weight of the Research? Jody Dushay, MD MMSc Beth Israel Deaconess Medical Center Boston, MA Session 445 No disclosures Disclosure Jody Dushay,
More informationCHEM 1406 BSA/BMI Measurement Laboratory (revised 01/03//06) BSA, Body Surface Area
CHEM 1406 BSA/BMI (revised 01/03//06) BSA, Body Surface Area See pages 105-110 of dosage text for equations, calculations and adult nomogram See pages 270-273 of dosage calculation text for pediatric nomogram
More informationFacts About Peripheral Arterial Disease (P.A.D.)
Facts About Peripheral Arterial Disease (P.A.D.) One in every 20 Americans over the age of 50 has P.A.D., a condition that raises the risk for heart attack and stroke. Peripheral arterial disease, or P.A.D.,
More informationTrend tables. Health Survey for England. A survey carried out on behalf of the Health and Social Care Information Centre. Joint Health Surveys Unit
Health Survey for England 2013 Trend tables 2 A survey carried out on behalf of the Health and Social Care Information Centre Joint Health Surveys Unit Department of Epidemiology and Public Health, UCL
More informationA Passage to India: Establishing a Cardiac Rehabilitation program in India s south-east
A Passage to India: Establishing a Cardiac Rehabilitation program in India s south-east Kathryn Kelly Clinical Nurse Consultant, Cardiac Rehabilitation Coordinator The Royal Melbourne Hospital India 1,025,000,000
More informationDiabetes and Obesity. The diabesity epidemic
Diabetes and Obesity Frank B. Diamond, Jr. M.D. Professor of Pediatrics University of South Florida College of Medicine The diabesity epidemic Prevalence of diabetes worldwide was over 135 million people
More informationINSULIN RESISTANCE, POLYCYSTIC OVARIAN SYNDROME
1 University of Papua New Guinea School of Medicine and Health Sciences Division of Basic Medical Sciences Discipline of Biochemistry and Molecular Biology PBL SEMINAR INSULIN RESISTANCE, POLYCYSTIC OVARIAN
More informationTherapeutic Approach in Patients with Diabetes and Coronary Artery Disease
Home SVCC Area: English - Español - Português Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease Martial G. Bourassa, MD Research Center, Montreal Heart Institute, Montreal, Quebec,
More informationOverview of Diabetes Management. By Cindy Daversa, M.S.,R.D.,C.D.E. UCI Health
Overview of Diabetes Management By Cindy Daversa, M.S.,R.D.,C.D.E. UCI Health Objectives: Describe the pathophysiology of diabetes. From a multiorgan systems viewpoint. Identify the types of diabetes.
More informationTechnology Assessment
Technology Assessment Lifestyle Interventions for Four Conditions: Type 2 Diabetes, Metabolic Syndrome, Breast Cancer, and Prostate Cancer Technology Assessment Program Prepared for: Agency for Healthcare
More informationDIABETES MELLITUS. By Tracey Steenkamp Biokineticist at the Institute for Sport Research, University of Pretoria
DIABETES MELLITUS By Tracey Steenkamp Biokineticist at the Institute for Sport Research, University of Pretoria What is Diabetes Diabetes Mellitus (commonly referred to as diabetes ) is a chronic medical
More informationBody Composition & Longevity. Ohan Karatoprak, MD, AAFP Clinical Assistant Professor, UMDNJ
Body Composition & Longevity Ohan Karatoprak, MD, AAFP Clinical Assistant Professor, UMDNJ LONGEVITY Genetic 25% Environmental Lifestyle Stress 75% BMI >30 OBESE 25-30 OVERWEIGHT 18-25 NORMAL WEIGHT 18
More informationMANAGEMENT OF LIPID DISORDERS: IMPLICATIONS OF THE NEW GUIDELINES
MANAGEMENT OF LIPID DISORDERS: IMPLICATIONS OF THE NEW GUIDELINES Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest EXPLAINING
More informationDRUG UTILIZATION EVALUATION OF ANTIHYPERTENSIVE DRUGS IN DIABETIC PATIENTS WITH CKD
WORLD JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES Elhami et al. SJIF Impact Factor 5.210 Volume 4, Issue 11, 1159-1166 Research Article ISSN 2278 4357 DRUG UTILIZATION EVALUATION OF ANTIHYPERTENSIVE
More information2012 Georgia Diabetes Burden Report: An Overview
r-,, 2012 Georgia Diabetes Burden Report: An Overview Background Diabetes and its complications are serious medical conditions disproportionately affecting vulnerable population groups including: aging
More informationClinical Research on Lifestyle Interventions to Treat Obesity and Asthma in Primary Care Jun Ma, M.D., Ph.D.
Clinical Research on Lifestyle Interventions to Treat Obesity and Asthma in Primary Care Jun Ma, M.D., Ph.D. Associate Investigator Palo Alto Medical Foundation Research Institute Consulting Assistant
More informationMarilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL
Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL www.goldcopd.com GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE GLOBAL STRATEGY FOR DIAGNOSIS, MANAGEMENT
More informationMain Effect of Screening for Coronary Artery Disease Using CT
Main Effect of Screening for Coronary Artery Disease Using CT Angiography on Mortality and Cardiac Events in High risk Patients with Diabetes: The FACTOR-64 Randomized Clinical Trial Joseph B. Muhlestein,
More informationDR. Trinh Thi Kim Hue
TYPE 2 DIABETES IN THE CHILD AND ADOLESCENT DR. Trinh Thi Kim Hue CONTENTS Definition Diagnosis Treatment Comorbidities and Complications Comorbidities and Complications Screening for T2D References DEFINITION
More informationMarkham Stouffville Hospital
Markham Stouffville Hospital Adult Diabetes Education Frequently Asked Questions What is diabetes? Diabetes is a disease in which blood glucose levels are above normal. Most of the food we eat is turned
More informationChronic Kidney Disease and the Electronic Health Record. Duaine Murphree, MD Sarah M. Thelen, MD
Chronic Kidney Disease and the Electronic Health Record Duaine Murphree, MD Sarah M. Thelen, MD Definition of Chronic Kidney Disease (CKD) Defined by the National Kidney Foundation Either a decline in
More information